Stephen Smolinski
Overview
Stephen Smolinski received $991K in total compensation, including $74K in salary, at Avalo Therapeutics in 2022. Stephen Smolinski also received an average of $967K at SELECTA BIOSCIENCES from 2017 to 2019.
Source: SEC filings on October 19, 2023, April 28, 2020, and April 29, 2019.
Related executives
We found 28 more executives who work or worked at Avalo Therapeutics and SELECTA BIOSCIENCES.
Garry Neil
Avalo Therapeutics
Chief Executive Officer
Michael Cola
Avalo Therapeutics
Chief Executive Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
Carsten Brunn
SELECTA BIOSCIENCES
Chief Executive Officer
Kevin Tan
SELECTA BIOSCIENCES
Chief Financial Officer
Schond Greenway
Avalo Therapeutics
Chief Financial Officer
Peter Traber
SELECTA BIOSCIENCES
Chief Medical Officer
Takashi Kishimoto
SELECTA BIOSCIENCES